209 related articles for article (PubMed ID: 18164870)
61. Clinical trials of a urethral dose measurement system in brachytherapy using scintillation detectors.
Suchowerska N; Jackson M; Lambert J; Yin YB; Hruby G; McKenzie DR
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):609-15. PubMed ID: 21093172
[TBL] [Abstract][Full Text] [Related]
62. Dosimetric comparison of tandem and Ovoids vs. tandem and ring for intracavitary gynecologic applications.
Levin D; Menhel J; Rabin T; Pfeffer MR; Symon Z
Med Dosim; 2008; 33(4):315-20. PubMed ID: 18973861
[TBL] [Abstract][Full Text] [Related]
63. Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial.
Belley MD; Craciunescu O; Chang Z; Langloss BW; Stanton IN; Yoshizumi TT; Therien MJ; Chino JP
Brachytherapy; 2018; 17(6):1023-1029. PubMed ID: 30150015
[TBL] [Abstract][Full Text] [Related]
64. Perineal template techniques for interstitial implantation of gynecological cancers using the Paris system of dosimetry.
Leung S
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):769-74. PubMed ID: 2211225
[TBL] [Abstract][Full Text] [Related]
65. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer.
Davidson SR; Weersink RA; Haider MA; Gertner MR; Bogaards A; Giewercer D; Scherz A; Sherar MD; Elhilali M; Chin JL; Trachtenberg J; Wilson BC
Phys Med Biol; 2009 Apr; 54(8):2293-313. PubMed ID: 19305043
[TBL] [Abstract][Full Text] [Related]
66. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer.
Beriwal S; Demanes DJ; Erickson B; Jones E; De Los Santos JF; Cormack RA; Yashar C; Rownd JJ; Viswanathan AN;
Brachytherapy; 2012; 11(1):68-75. PubMed ID: 22265440
[TBL] [Abstract][Full Text] [Related]
67. Dosimetric characterization of 142Pr glass seeds for brachytherapy.
Jung JW; Reece WD
Appl Radiat Isot; 2008 Apr; 66(4):441-9. PubMed ID: 18171619
[TBL] [Abstract][Full Text] [Related]
68. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
[TBL] [Abstract][Full Text] [Related]
69. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy.
Georg P; Kirisits C; Goldner G; Dörr W; Hammer J; Pötzi R; Berger D; Dimopoulos J; Georg D; Pötter R
Radiother Oncol; 2009 May; 91(2):173-80. PubMed ID: 19243846
[TBL] [Abstract][Full Text] [Related]
70. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy.
Sahgal A; Jabbari S; Chen J; Pickett B; Roach M; Weinberg V; Hsu IC; Pouliot J
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):247-54. PubMed ID: 18722275
[TBL] [Abstract][Full Text] [Related]
71. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
[TBL] [Abstract][Full Text] [Related]
72. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
[TBL] [Abstract][Full Text] [Related]
73. Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): patterns of care study in Japan.
Toita T; Kodaira T; Shinoda A; Uno T; Akino Y; Mitsumori M; Teshima T
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):788-94. PubMed ID: 18191331
[TBL] [Abstract][Full Text] [Related]
74. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy.
Ghadjar P; Keller T; Rentsch CA; Isaak B; Behrensmeier F; Stroux A; Thalmann GN; Aebersold DM
Brachytherapy; 2009; 8(1):45-51. PubMed ID: 19038584
[TBL] [Abstract][Full Text] [Related]
75.
Matsumoto S; Matsufuji N; Koba Y; Tsuji H
Anticancer Res; 2023 May; 43(5):2259-2264. PubMed ID: 37097649
[TBL] [Abstract][Full Text] [Related]
76. Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1335-43. PubMed ID: 19386443
[TBL] [Abstract][Full Text] [Related]
77. Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients.
van Haaren PM; Bel A; Hofman P; van Vulpen M; Kotte AN; van der Heide UA
Radiother Oncol; 2009 Mar; 90(3):291-8. PubMed ID: 19195732
[TBL] [Abstract][Full Text] [Related]
78. Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index.
Shi C; Peñagarícano J; Papanikolaou N
Med Dosim; 2008; 33(3):215-21. PubMed ID: 18674686
[TBL] [Abstract][Full Text] [Related]
79. Online in vivo dosimetry in high dose rate prostate brchytherapy with MOSkin detectors: in phantom feasibility study.
Gambarini G; Carrara M; Tenconi C; Mantaut N; Borroni M; Cutajar D; Petasecca M; Fuduli I; Lerch M; Pignoli E; Rosenfeld A
Appl Radiat Isot; 2014 Jan; 83 Pt C():222-6. PubMed ID: 23810727
[TBL] [Abstract][Full Text] [Related]
80. Time-resolved in vivo dosimetry for source tracking in brachytherapy.
Johansen JG; Rylander S; Buus S; Bentzen L; Hokland SB; Søndergaard CS; With AKM; Kertzscher G; Tanderup K
Brachytherapy; 2018; 17(1):122-132. PubMed ID: 28943129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
